Learn more about our dynamic reporting capabilities with our precision medicine software.
We are committed to improving the quality of life for patients struggling with mental health conditions. With Neuropharmagen®, we combine genetic testing and lifestyle factors to deliver a dynamic, individualized patient report. Additionally, our portal helps providers clearly identify safer and more effective medications for their patients.
Ordering a Neuropharmagen® test is a seamless process for providers. To initiate an order, simply follow the three easy steps outlined below. Neuropharmagen® must be ordered by a licensed healthcare professional capable of prescribing medications. Patients can work with their healthcare provider to facilitate the ordering of a Neuropharmagen® test and subsequently reviewing the test results. Our goal is to ensure a hassle-free experience from start to finish.
Complete Online Form
Start by completing our online form with your provider credentials, practice, and contact information.
One of our customer service representatives will contact you within 24 hours to set up your Aina portal account for ordering.
Aina Portal Login
Begin Ordering Tests
Order test through the Aina provider portal. Collection kits will go directly to the patient and you will be notified once report results are ready.
For patients who are struggling to find the right psychotropic treatment, Neuropharmagen® can help guide you to safer, more effective medication alternatives. With our PGx solution provides tailored dose recommendations based on a patient’s genotype to achieve better adherence with reduced side-effects.
Neuropharmagen® provides information for 62 psychoactive drugs for which relevant scientific evidence on pharmacogenetics is available.
Neuropharmagen® analyzes over 75 genetic polymorphisms in 34 genes, selected in accordance with the available pharmacogenetic evidence.
Neuropharmagen® uses an easy-to-interpret color coding system to highlight gene-drug interaction alerts, and visual icons for drug-drug and drug-clinical-physiological interactions.